A detailed history of Artisan Partners Limited Partnership transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 4,803,825 shares of IOVA stock, worth $39.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,803,825
Previous 5,111,409 6.02%
Holding current value
$39.1 Million
Previous $41 Million 10.04%
% of portfolio
0.07%
Previous 0.07%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$7.28 - $11.9 $2.24 Million - $3.66 Million
-307,584 Reduced 6.02%
4,803,825 $45.1 Million
Q2 2024

Aug 12, 2024

SELL
$7.78 - $14.19 $208,605 - $380,476
-26,813 Reduced 0.52%
5,111,409 $41 Million
Q1 2024

May 13, 2024

BUY
$7.59 - $17.47 $2.36 Million - $5.43 Million
310,552 Added 6.43%
5,138,222 $76.1 Million
Q4 2023

Feb 12, 2024

SELL
$3.3 - $8.89 $689,069 - $1.86 Million
-208,809 Reduced 4.15%
4,827,670 $39.2 Million
Q3 2023

Nov 09, 2023

BUY
$4.44 - $8.79 $2.71 Million - $5.36 Million
609,738 Added 13.77%
5,036,479 $22.9 Million
Q2 2023

Aug 10, 2023

BUY
$5.36 - $9.06 $4.6 Million - $7.77 Million
858,035 Added 24.04%
4,426,741 $31.2 Million
Q1 2023

May 11, 2023

BUY
$5.53 - $8.22 $4.61 Million - $6.85 Million
832,974 Added 30.45%
3,568,706 $21.8 Million
Q4 2022

Feb 10, 2023

SELL
$5.62 - $10.0 $128,366 - $228,410
-22,841 Reduced 0.83%
2,735,732 $17.5 Million
Q3 2022

Nov 10, 2022

SELL
$9.53 - $13.11 $192,782 - $265,202
-20,229 Reduced 0.73%
2,758,573 $26.4 Million
Q2 2022

Aug 12, 2022

BUY
$6.38 - $18.33 $426,107 - $1.22 Million
66,788 Added 2.46%
2,778,802 $30.7 Million
Q1 2022

May 13, 2022

BUY
$12.38 - $19.1 $300,635 - $463,824
24,284 Added 0.9%
2,712,014 $45.2 Million
Q4 2021

Feb 11, 2022

SELL
$16.55 - $27.63 $2.99 Million - $4.99 Million
-180,565 Reduced 6.3%
2,687,730 $51.3 Million
Q3 2021

Nov 12, 2021

SELL
$20.35 - $26.63 $2.16 Million - $2.82 Million
-106,039 Reduced 3.57%
2,868,295 $70.7 Million
Q2 2021

Aug 12, 2021

SELL
$16.33 - $33.07 $143,377 - $290,354
-8,780 Reduced 0.29%
2,974,334 $77.4 Million
Q1 2021

May 11, 2021

BUY
$28.67 - $52.59 $2.28 Million - $4.19 Million
79,645 Added 2.74%
2,983,114 $94.4 Million
Q4 2020

Feb 10, 2021

BUY
$28.04 - $50.26 $2 Million - $3.58 Million
71,231 Added 2.52%
2,903,469 $135 Million
Q3 2020

Nov 12, 2020

SELL
$27.75 - $36.3 $4.38 Million - $5.73 Million
-157,915 Reduced 5.28%
2,832,238 $93.2 Million
Q2 2020

Aug 12, 2020

BUY
$27.21 - $41.0 $32.4 Million - $48.7 Million
1,188,943 Added 66.01%
2,990,153 $82.1 Million
Q1 2020

May 12, 2020

BUY
$19.54 - $38.85 $3.05 Million - $6.06 Million
156,093 Added 9.49%
1,801,210 $53.9 Million
Q4 2019

Feb 12, 2020

BUY
$17.95 - $29.41 $7.76 Million - $12.7 Million
432,569 Added 35.67%
1,645,117 $45.5 Million
Q3 2019

Nov 12, 2019

BUY
$17.99 - $26.0 $3.19 Million - $4.61 Million
177,152 Added 17.11%
1,212,548 $22.1 Million
Q2 2019

Aug 09, 2019

BUY
$9.78 - $24.52 $10.1 Million - $25.4 Million
1,035,396 New
1,035,396 $25.4 Million

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.